Safety of high doses of somatostatin analogs in well differentiated NENs in elderly
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz245.008
Abstract: Abstract Background Neuroendocrine neoplasms (NENs) are a group of heterogeneous neoplasms which can be treated with different therapies: in well differentiated (WD) NENs analogs of somatostatin (SSA) can be used considering their proved antineoplastic and… read more here.
Keywords: age; differentiated nens; well differentiated; high doses ... See more keywords